Evidence map›Paper›PMID 40233033›Full record

ArticlePLoS biology2025

Expanding the bat toolbox: Carollia perspicillata bat cell lines and reagents enable the characterization of viral susceptibility and innate immune responses.

Victoria Gonzalez, Cierra Word, Nahomi Guerra-Pilaquinga, Mitra Mazinani, Stephen Fawcett, Christine Portfors, Darryl Falzarano, Alison M Kell, Rohit K Jangra, Arinjay Banerjee and 2 more

Abstract read
In one paragraph

Article in PLoS biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Chiropteran (Animals : an open access journal from MDPI · 2026
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Victoria GonzalezVaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Canada.
Cierra WordLouisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.
Nahomi Guerra-PilaquingaLouisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.
Mitra MazinaniPaul G. Allen School for Global Health, Washington State University, Pullman, Washington, United States of America.
Stephen FawcettPaul G. Allen School for Global Health, Washington State University, Pullman, Washington, United States of America.
Christine PortforsWashington State University, Vancouver, Washington, United States of America.
Darryl FalzaranoVaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Canada.
Alison M KellDepartment of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, New Mexico, United States of America.
Rohit K JangraLouisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.
Arinjay BanerjeeVaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, Canada.
Stephanie N SeifertPaul G. Allen School for Global Health, Washington State University, Pullman, Washington, United States of America.
Michael LetkoPaul G. Allen School for Global Health, Washington State University, Pullman, Washington, United States of America.ORCID https://orcid.org/0000-0002-7640-2861

Funding

Project 4-Tracking cytomegalovirus-primed long-lived NK cells in salivary glandP20GM134974 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ANDREW D YUROCHKO · 2021 to 2026
$15.0M
Viral and host determinants of susceptibility of diverse hantavirusesR21AI156482 · NIAID · LOUISIANA STATE UNIV HSC SHREVEPORT · PI JANGRA, ROHIT K · 2021 to 2022
$452k
Assessing the interferome in novel, purpose-driven bat-derived cellsR21AI169527 · NIAID · WASHINGTON STATE UNIVERSITY · PI BANERJEE, ARINJAY, LETKO, MICHAEL · 2022 to 2023
$362k
NIAID NIH HHS R21 AI156482NIAID NIH HHS R21 AI169527NIGMS NIH HHS P20 GM134974
6 · The paper itself

Abstract

Multiple viruses that are highly pathogenic in humans are known to have evolved in bats. How bats tolerate infection with these viruses, however, is poorly understood. As viruses engage in a wide range of interactions with their hosts, it is essential to study bat viruses in a system that resembles their natural environment like bat-derived in vitro cellular models. However, stable and accessible bat cell lines are not widely available for the broader scientific community. Here, we generated in vitro reagents for the Seba's short-tailed bat (Carollia perspicillata), tested multiple methods of immortalization, and characterized their susceptibility to virus infection and response to immune stimulation. Using pseudotyped virus library and authentic virus infections, we show that these C. perspicillata cell lines derived from a diverse array of tissues are susceptible to viruses bearing the glycoprotein of numerous orthohantaviruses, including Andes and Hantaan virus and are also susceptible to live hantavirus infection. Furthermore, stimulation with synthetic double-stranded RNA prior to infection with vesicular stomatitis virus and Middle Eastern respiratory syndrome coronavirus induced a protective antiviral response, demonstrating the suitability of our cell lines to study the bat antiviral immune response. Taken together, the approaches outlined here will inform future efforts to develop in vitro tools for virology from non-model organisms and these C. perspicillata cell lines will enable studies on virus-host interactions in these bats.

Indexed as

ChiropteraImmunity, InnateAnimalsCell LineHumansOrthohantavirus

Identifiers

PMID40233033
PMCPMC11999112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.